OpenAlex
PricingAboutJobs
Log inGet started
Work

Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double‐blind, placebo‐controlled, dose‐escalating, single‐ and repeated‐dose study

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.23178
Authors: P. P. Tak, R. M. Thurlings, C. Rossier, I. Nestorov, A. Dimic, V. Mircetic, M. Rischmueller, E. Nasonov, E. Shmidt, P. Emery, A. Munafo
Institutions: Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Merck Serono S.A. (Switzerland), Queen Elizabeth Hospital, City Clinical Hospital, Leeds General Infirmary
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: atacicept, rheumatoid arthritis, B lymphocyte stimulator, proliferation-inducing ligand, B-cell depletion, pharmacokinetics, pharmacodynamics, tolerability, anti-citrullinated protein antibodies, rheumatoid factor, immunoglobulin levels, dose escalation, B cell response
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2008925400
FWCI: 13.82
Cites: 23
Cited by: 215
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms